187 related articles for article (PubMed ID: 30918065)
1.
Dongiovanni P; Meroni M; Baselli G; Mancina RM; Ruscica M; Longo M; Rametta R; Cespiati A; Pelusi S; Ferri N; Ranzani V; Nobili V; Pihlajamaki J; Fracanzani AL; Badiali S; Petta S; Fargion S; Romeo S; Kozlitina J; Valenti L
J Lipid Res; 2019 Jun; 60(6):1144-1153. PubMed ID: 30918065
[TBL] [Abstract][Full Text] [Related]
2. The rs508487, rs236911, and rs236918 Genetic Variants of the Proprotein Convertase Subtilisin-Kexin Type 7 (
Vargas-Alarcón G; Pérez-Méndez O; González-Pacheco H; Ramírez-Bello J; Posadas-Sánchez R; Escobedo G; Fragoso JM
Cells; 2021 Jun; 10(6):. PubMed ID: 34207761
[TBL] [Abstract][Full Text] [Related]
3. PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease.
Sachan V; Le Dévéhat M; Roubtsova A; Essalmani R; Laurendeau JF; Garçon D; Susan-Resiga D; Duval S; Mikaeeli S; Hamelin J; Evagelidis A; Chong M; Paré G; Chernetsova E; Gao ZH; Robillard I; Ruiz M; Trinh VQ; Estall JL; Faraj M; Austin RC; Sauvageau M; Prat A; Kiss RS; Seidah NG
Metabolism; 2024 Jan; 150():155736. PubMed ID: 37967646
[TBL] [Abstract][Full Text] [Related]
4. Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication.
Furuhashi M; Kataoka Y; Nishikawa R; Koyama M; Sakai A; Higashiura Y; Tanaka M; Saitoh S; Shimamoto K; Ohnishi H
J Atheroscler Thromb; 2022 Sep; 29(9):1275-1284. PubMed ID: 34565765
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
[TBL] [Abstract][Full Text] [Related]
6. Proprotein convertase 7 (PCSK7) reduces apoA-V levels.
Ashraf Y; Duval S; Sachan V; Essalmani R; Susan-Resiga D; Roubtsova A; Hamelin J; Gerhardy S; Kirchhofer D; Tagliabracci VS; Prat A; Kiss RS; Seidah NG
FEBS J; 2020 Aug; 287(16):3565-3578. PubMed ID: 31945259
[TBL] [Abstract][Full Text] [Related]
7. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
8. Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study.
Eshraghian A; Moasser E; Azarpira N; Fattahi MR; Nikeghbalian S; Malek-Hosseini SA; Geramizadeh B
BMC Gastroenterol; 2021 Dec; 21(1):458. PubMed ID: 34876018
[TBL] [Abstract][Full Text] [Related]
9. Proprotein convertase subtilisin/kexin type 7 (PCSK7) is essential for the zebrafish development and bioavailability of transforming growth factor β1a (TGFβ1a).
Turpeinen H; Oksanen A; Kivinen V; Kukkurainen S; Uusimäki A; Rämet M; Parikka M; Hytönen VP; Nykter M; Pesu M
J Biol Chem; 2013 Dec; 288(51):36610-23. PubMed ID: 24178295
[TBL] [Abstract][Full Text] [Related]
10. Liver fat accumulation is associated with circulating PCSK9.
Ruscica M; Ferri N; Macchi C; Meroni M; Lanti C; Ricci C; Maggioni M; Fracanzani AL; Badiali S; Fargion S; Magni P; Valenti L; Dongiovanni P
Ann Med; 2016 Aug; 48(5):384-91. PubMed ID: 27222915
[TBL] [Abstract][Full Text] [Related]
11. Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis.
Pelucchi S; Galimberti S; Greni F; Rametta R; Mariani R; Pelloni I; Girelli D; Busti F; Ravasi G; Valsecchi MG; Valenti L; Piperno A
J Gastroenterol Hepatol; 2016 Jul; 31(7):1342-8. PubMed ID: 26868056
[TBL] [Abstract][Full Text] [Related]
12. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
[TBL] [Abstract][Full Text] [Related]
13. Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study.
Pasta A; Borro P; Cremonini AL; Formisano E; Tozzi G; Cecchi S; Fresa R; Labanca S; Djahandideh A; Sukkar SG; Picciotto A; Pisciotta L
Pharmacol Res Perspect; 2021 Oct; 9(5):e00820. PubMed ID: 34476902
[TBL] [Abstract][Full Text] [Related]
14. Building bridges: PCSK7 as a NAFLD candidate gene connecting hepatic inflammation with hypertriglyceridemia.
Carr RM; Davidson NO
J Lipid Res; 2019 Jun; 60(6):1067-1068. PubMed ID: 31023721
[No Abstract] [Full Text] [Related]
15. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Chi X; Qu N; Wang C
Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Petta S; Valenti L; Svegliati-Baroni G; Ruscica M; Pipitone RM; Dongiovanni P; Rychlicki C; Ferri N; Cammà C; Fracanzani AL; Pierantonelli I; Di Marco V; Meroni M; Giordano D; Grimaudo S; Maggioni M; Cabibi D; Fargion S; Craxì A
J Clin Endocrinol Metab; 2017 Aug; 102(8):2660-2669. PubMed ID: 28472477
[TBL] [Abstract][Full Text] [Related]
18. Novel association to the proprotein convertase PCSK7 gene locus revealed by analysing soluble transferrin receptor (sTfR) levels.
Oexle K; Ried JS; Hicks AA; Tanaka T; Hayward C; Bruegel M; Gögele M; Lichtner P; Müller-Myhsok B; Döring A; Illig T; Schwienbacher C; Minelli C; Pichler I; Fiedler GM; Thiery J; Rudan I; Wright AF; Campbell H; Ferrucci L; Bandinelli S; Pramstaller PP; Wichmann HE; Gieger C; Winkelmann J; Meitinger T
Hum Mol Genet; 2011 Mar; 20(5):1042-7. PubMed ID: 21149283
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
20. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.
Latorre J; Moreno-Navarrete JM; Mercader JM; Sabater M; Rovira Ò; Gironès J; Ricart W; Fernández-Real JM; Ortega FJ
Int J Obes (Lond); 2017 Apr; 41(4):620-630. PubMed ID: 28119530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
